Spots Global Cancer Trial Database for Mobile Application to Assist Adherence to Oral Anticancer Agents and Symptom Management

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Mobile Application to Assist Adherence to Oral Anticancer Agents and Symptom Management

Official Title: The Effect of a Mobile Application on Treatment Adherence and Symptom Management in Patients Using Oral Anticancer Agents: A Randomized Controlled Trial

Study ID: NCT04626830

Conditions

Cancer

Adherence to Medication Regime

Symptom Management

Interventions

Mobile Application Intervention

Study Description

Brief Summary: The use of oral anticancer agents (OAAs) in cancer treatment has increased especially in the last two decades. The use of mobile health technologies in the management of OAA can be beneficial in terms of treatment adherence and symptom management.The aim of this study is to explore how a Smartphone mobile application can help improve the cancer treatment process in people who are used oral anticancer agents. This study will be done a randomized-controlled trial to test the intervention.

Detailed Description: Background: The use of mobile health technologies in the management of OAA can be beneficial in terms of treatment adherence and symptom management. Objective/Hipothesis: The purpose of this study is to explore the effectiveness of a mobile application on treatment adherence and symptom management in patients using OAA. The following hypotheses (H) will teste in this study: H0a: A mobile application developed for patients using OAA has not increased treatment adherence. H1a: A mobile application developed for patients using OAA has increased treatment adherence. H0b: A mobile application developed for patients using OAA has not decreased the frequency and severity of symptoms. H1b: A mobile application developed for patients using OAA has decreased the frequency and severity of symptoms. Study Design: The investigators will recruit and randomly assign 100 patients from the two cancer care sites who have recently been prescribed oral anticancer agents to receive either the mobile app intervention or standard care. Participants will be stratified by age and anticancer treatment ( i.e. simple and complex) regimen. Patients will be follow 6 months. Medication adherence, symptom severity will serve as primary outcomes.